Your browser doesn't support javascript.
loading
Use of allopathic and complementary medicine for preventing SARS-CoV-2 infection in Mexican adults: A national survey.
Ruiz-Padilla, Alan Joel; Alonso-Castro, Angel Josabad; Preciado-Puga, Mónica; González-Núñez, Ariadna Irais; González-Chávez, José Lorenzo; Ruiz-Noa, Yeniley; Ortiz-Cortes, Miriam; Brennan-Bourdon, Lorena Michele; Deveze-Álvarez, Martha Alicia.
Afiliación
  • Ruiz-Padilla AJ; Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico.
  • Alonso-Castro AJ; Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico.
  • Preciado-Puga M; Departamento de Medicina y Nutrición, División de Ciencias de la Salud, Universidad de Guanajuato, León, Guanajuato, Mexico.
  • González-Núñez AI; Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico.
  • González-Chávez JL; Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico.
  • Ruiz-Noa Y; Departamento de Ciencias Médicas, División de Ciencias de la Salud, Universidad de Guanajuato, León, Guanajuato, Mexico.
  • Ortiz-Cortes M; Doctorado Interinstitucional en Arte y Cultura, Universidad Autónoma de Aguascalientes, Aguascalientes, Aguascalientes, Mexico.
  • Brennan-Bourdon LM; Comisión para la Protección Contra Riesgos Sanitarios del Estado de Jalisco, Guadalajara, Jalisco, Mexico.
  • Deveze-Álvarez MA; Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Mexico.
Saudi Pharm J ; 29(9): 1056-1060, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34305423
BACKGROUND: The aim of this study was to assess the frequency of allopathic and complementary medicine use for preventing the infection with SARS-CoV-2 in Mexico. A descriptive and cross-sectional study was conducted using an online questionnaire among general adult population (n = 16,724) of the 32 Mexican states from March to November 2020. METHODS: The factors associated with the use, self-medication practice, and adverse reactions due the consumption of allopathic and complementary medicine to prevent infection with SARS-CoV-2 virus were assessed using a structured questionnaire. The suspected adverse reactions associated with the use of drugs or complementary medicine were reported. RESULTS: The prevalence (42.9%) of allopathic and/or complementary medicine use for preventing SARS-CoV-2 infection was mainly associated with unemployment [OR:2.026 (1.722-2.283)]. Acetaminophen (n = 2272) and vitamin C (n = 3252) were the main allopathic and complementary medicine products used to prevent SARS-CoV-2 infection, respectively. The prevalence of self-medication and adverse reactions was 35.3% and 4.8%, respectively. Self-medication [OR:1.930 (1.633-2.282)] and adverse reactions [OR:2.603 (2.015-3.363)] were mainly associated with individuals of low socioeconomic status. Hydroxychloroquine (21.2%) and chloroquine (15.2%) showed the highest prevalence of adverse reactions, which were mainly related to gastrointestinal disorders. CONCLUSION: The use of medications and complementary medicine to prevent SARS-CoV-2 infection is prevalent (almost one-half of the respondents) among Mexican population, and it is mainly associated with unemployment. Self-medication and the adverse reactions derived from self-medication are also prevalent and seem to be influenced by low socioeconomic status.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies País/Región como asunto: Mexico Idioma: En Revista: Saudi Pharm J Año: 2021 Tipo del documento: Article País de afiliación: México Pais de publicación: Arabia Saudita
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Qualitative_research / Risk_factors_studies País/Región como asunto: Mexico Idioma: En Revista: Saudi Pharm J Año: 2021 Tipo del documento: Article País de afiliación: México Pais de publicación: Arabia Saudita